bBHC has applied 470 patents related with nEPS over 147 countries and 309 patents are registered in US, EU, Israel, Singapore, Russia, China etc.
bBHC welcomes collaborative research opportunities with global research centers and multinational pharmaceutical companies. Also, nEPS can be provided at your request any time for the purpose of research and development.
We participate many international biotechnology congresses to present our technology and please contact us to the below address for any inquiries.
∙ Company Name: bBHC co.,Ltd
∙ Established: 2012. 11. 01
∙ CEO: Mindy Minsun Oh
∙ Main business segments : stem cell research, cell therapy development, the cosmetics business
∙ Email: firstname.lastname@example.org